Nirmatrelvir treatment duration and frequency of COVID-19 rebound
{{output}}
Background: Nirmatrelvir has been shown to reduce morbidity and mortality associated with COVID-19. However, it is underutilized due to concerns regarding COVID-19 symptom rebound following nirmatrelvir's standard 5-day course. ... ...
